The level of COL1A2 was reduced in the proteome of AML-MSCs at the onset (Log2FC = 0.26, p = 0.036) and remission (Log2FC = 0.48, p = 0.006) compared to D-MSCs. The gene discussed is COL1A2; the disease is acute myeloid leukemia.